A2780cis Cell Line
The cisplatin-resistant A2780cis cell line has been developed by chronic exposure of the parent cisplatin-sensitive A2780 cell line
Contributors
| Inventor | Institute |
|---|---|
| Timothy Ward | National Cancer Institute |
| Cat. #: | 152708 |
|---|---|
| Tool sub type: | Continuous |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Gynaecologic cancer |
| Research Fields: | Cancer;Drug development |
| Organism: | Human |
| Tissue: | Ovary |
| Gender: | Female |
| Model: | Tumour line |
| Morphology: | Epithelial |
| Growth properties: | Adherant |
| Cancer Types In Detail: | Human ovarian carcinoma |
| Alternate name: | A2780 cis; A2780/cis; A2780-cis; A2780CIS; A2780cis Cells; cisplatin-resistant cell line |
|---|---|
| Product description: | A2780 cell line resistant to cisplatin. Background and Research Application The cisplatin-resistant A2780cis cell line has been developed by chronic exposure of the parent cisplatin-sensitive A2780 cell line (catalogue no. 152706) to increasing concentrations of cisplatin. This cell line was derived from a patient with ovarian endometroid adenocarcinoma. A2780cis is cross-resistant to melphalan, adriamycin and irradiation. An increased ability to repair DNA damage as well as cytogenetic abnormalities has been observed. In order to retain resistance cisplatin has to be added to the media for every passage. In addition to this matched pair of drug-sensitive/resistant cell lines an adriamycin-resistant cell line, A2780adr (catalogue no. 152707), has been isolated from the same parental line. A2780cis has been used in a variety of experiments, including studying the cytotoxic effects of platinum (II) complexes and gold (I)-triphenylphosphine complexes with hypoxanthine-derived ligands. It has also been used to study the effects of cancer-cell specific oligopeptides. |
| Gender: | Female |
| Conditional: | Yes |
| Production details: | Split sub-confluent cultures (70-80%) 1:5 to 1:20 i.e. seeding at 1×1,000 to 1×10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C. Cells will attach slowly after resuscitation and take up to 7 days to reach confluency. Recommendation: resuscitate cells in media without cisplatin. Add after subculture of attached cells. |
| Additional notes: | Points of Interest This cell line has also been used in toxicity testing and drug resistance studies. Karyotype: Modal no. 46 STR-PCR Data: Amelogenin: X CSF1PO: 10,11 D13S317: 13 D16S539: 11,13 D5S818: 11 D7S820: 10 THO1: 6 TPOX: 8,10 vWA: 15,16 Concentration Vial has between 1-5 million cells as standard, however this may vary. |
| Cellosaurus ID: | CVCL_1942 |
| Parental cell line: | A2780 |
| disease: | Cancer |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | RPMI 1640 + 2mM Glutamine + 1µM cisplatinum + 10% Foetal Bovine Serum (FBS). To retain resistance cisplatin must be added to the media every 2-3 passages. |
| Subculture routine: | Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4 x10,000cells/cm² using 0.05% trypsin or trypsin/EDTA; 5% CO₂; 37°C. Cells will attach slowly after resuscitation and take up to 7 days to reach confluency. Recommendation: resuscitate cells in media without cisplatin. Add after subculture of attached cells. |
| References: |
Wang et al. 2015. Theranostics. 5(4): 431-442. PMID: 25699101. Starha et al. 2014. PLoS One. 9(3):e90341. PMID: 24603594 Beaufort et al. 2014. PLoS One. 9(9):e103988. PMID: 25230021. Marcotte et al. 2012. Cancer Discov. 2(2):172-189. PMID: 22585861. Rothenberg et al. 2010. Cancer Res. 70(6):2158-2164. PMID: 20215515. Masuda et al. 1988. Cancer Res. 48(20):5713-5716. PMID: 3139281. Behrens et al. 1987. Cancer Res. 47(2):414-418. PMID: 3539322. |
|---|
Related Tools for Cell lines
| Cat. # | Tool Name | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151447 | CMT 64 Cell Line |
Key Info
CMT 64 Cell Line
|
View Tool | |||||||||||||
| 151480 | HEK293A EGFP-LC3 Cell Line |
Key Info
HEK293A EGFP-LC3 Cell Line
|
View Tool | |||||||||||||
| 151558 | MEF Trex1 KO Cell Line |
Key Info
MEF Trex1 KO Cell Line
|
View Tool | |||||||||||||
| 151655 | FLYA-13 Cell Line |
Key Info
FLYA-13 Cell Line
|
View Tool | |||||||||||||
| 151665 | MEF PKCe KO Cell Line |
Key Info
MEF PKCe KO Cell Line
|
View Tool | |||||||||||||
